Prognosis: Breakthrough

The Global Vaccine Gap

Prognosis: Breakthrough

In a race to catch up with emerging coronavirus variants, wealthy countries are already benefiting from potent vaccines. While the U.S., Britain and European Union have given citizens aboutย 24 millionย doses so far -- more than half of the shots administered globally -- vast numbers of countries have yet to begin their campaigns. James Paton reports that these disparities pose a threat to both have and have-not states. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

Next Episodes

Prognosis: Breakthrough

Where to Be in a Pandemic (Rebroadcast) @ Prognosis: Breakthrough

๐Ÿ“† 2021-01-18 20:56 / โŒ› 00:17:36


Prognosis: Breakthrough

Can We Fix the Chaotic Vaccine Rollout? @ Prognosis: Breakthrough

๐Ÿ“† 2021-01-15 20:30 / โŒ› 00:17:35


Prognosis: Breakthrough

Why Healthcare Workers Refuse the Vaccine @ Prognosis: Breakthrough

๐Ÿ“† 2021-01-13 21:56 / โŒ› 00:16:24


Prognosis: Breakthrough

What Allergic Vaccine Reactions Mean For You @ Prognosis: Breakthrough

๐Ÿ“† 2021-01-11 22:24 / โŒ› 00:14:47


Prognosis: Breakthrough

The U.K. Health System Threatens to Buckle @ Prognosis: Breakthrough

๐Ÿ“† 2021-01-08 21:14 / โŒ› 00:17:52